Middle East and Africa Hypodermic Needles Market Share by Size and Growth 2028

The Middle East & Africa hypodermic needles market is expected to reach US$ 174.2 million by 2028 from US$ 117.6 million in 2021. The market is estimated to grow at a CAGR of 5.8% from 2021–2028.

Diabetes is another life-threatening chronic disease with no functional cure. Diabetes of all types can lead to various complications in different parts of the body and increase the overall risk of premature death. Heart attack, stroke, kidney failure, leg amputation, vision loss, and nerve damage are the major complications associated with diabetes. In diabetic patients, the exogenous insulin is usually administered through a subcutaneous route of administration for diabetes management. The wide acceptance of hypodermic needles for insulin delivery, enabling self-administration and accurate dosing, is driving the hypodermic needles market significantly. Also, most biotherapeutics are injected using a hypodermic needle injection as they provide a low-cost, rapid, and direct way to deliver almost any type of molecule into the body. Hence, the adoption of the hypodermic needle is increasing, leading to high Middle East & Africa market growth.

The Kingdom of Saudi Arabia was one of the first countries to implement a COVID-19 vaccination program. Addressing sociodemographic determinants relating to the COVID-19 vaccination may help to increase uptake of the global vaccination program to tackle future pandemics. The COVID-19 pandemic has necessitated rapid vaccine development for the control of the disease. Most vaccinations, including those currently approved for COVID-19 are administered intramuscularly and subcutaneously using hypodermic needles. Thus, the market is positively impacted due to COVID-19.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the hypodermic needles market. The Middle East & Africa hypodermic needles market is expected to grow at a good CAGR during the forecast period.

Middle East & Africa Hypodermic Needles Market Revenue and Forecast to 2028 (US$ Million)

Middle East & Africa Hypodermic Needles Market Segmentation

By Type

Safety Needles
- Retractable Needles
- Non-retractable Needles
Non-safety Needles

By Application

Drug Delivery
Vaccination
Blood Specimen Collection

By End User

Hospitals and Clinics
Diagnostic Centers
Home Health Care

By Usage

Disposable
Reusable

By Country

Middle East & Africa
- UAE
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa

Companies Mentioned

Terumo Corporation
BD
B. Braun Melsungen AG
Catalent Inc
Cardinal Health Inc
Barber of Sheffield

Middle East and Africa Hypodermic Needles Market Strategic Insights

Get more information on this report

Middle East and Africa Hypodermic Needles Market Segmentation Analysis

Middle East and Africa Hypodermic Needles Market Report Highlights

Middle East and Africa Hypodermic Needles Report Scope

Report Attribute	Details
Market size in 2021	US$ 117.6 Million
Market Size by 2028	US$ 174.2 Million
CAGR (2021 - 2028)	5.8%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Type Safety Needles Non-safety Needles By Application Drug Delivery Vaccination Blood Specimen Collection By End-Users Diagnostic Centers Hospitals and Clinics Home Health Care By Usage Disposable Reusable
Regions and Countries Covered	Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Terumo Corporation BD B. Braun Melsungen AG Catalent Inc Cardinal Health Inc Barber of Sheffield